Your browser doesn't support javascript.
loading
Addition of MPS-II to the Recommended Uniform Screening Panel in the United States.
Millington, David S; Ficicioglu, Can.
Affiliation
  • Millington DS; Department of Pediatrics, Division of Medical Genetics, Duke University Medical Center, Durham, NC 27709, USA.
  • Ficicioglu C; Section of Biochemical Genetics, Division of Genetics, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
Int J Neonatal Screen ; 8(4)2022 Oct 11.
Article in En | MEDLINE | ID: mdl-36278625
It has recently been announced that the Secretary of the U.S. Department of Health and Human Services has approved the recommendation by the Advisory Committee on Heritable Disorders in Newborns and Children (ACHDNC) to add mucopolysaccharidosis type II (MPS-II, Hunter Syndrome) to the recommended uniform screening panel (RUSP) in the United States [...].

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Diagnostic_studies / Screening_studies Language: En Journal: Int J Neonatal Screen Year: 2022 Document type: Article Affiliation country: Estados Unidos Country of publication: Suiza

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Diagnostic_studies / Screening_studies Language: En Journal: Int J Neonatal Screen Year: 2022 Document type: Article Affiliation country: Estados Unidos Country of publication: Suiza